Question 1

Does Arrowstreet Capital own GSK1 stock?

Accepted Answer

As of its Q2 2022 13F, Arrowstreet Capital held 9,989,614 shares of GSK1 (Glaxosmithkline), worth $434.8M.

Question 2

How many shares of GSK1 does Arrowstreet Capital own?

Accepted Answer

As of its Q2 2022 13F, Arrowstreet Capital held 9,989,614 shares of GSK1 (Glaxosmithkline).

Question 3

What is Arrowstreet Capital's GSK1 position worth?

Accepted Answer

As of its Q2 2022 13F, Arrowstreet Capital's GSK1 position was worth $434.8M.

Question 4

When did Arrowstreet Capital first buy GSK1?

Accepted Answer

Arrowstreet Capital already held GSK1 in its Q4 2018 13F, the earliest on record, and listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$25.18	0
2022-Q2	Increased	10M	+3.8%	$434.8M	0.6%	$36.82	46
2022-Q1	Increased	9.6M	+32.5%	$419.1M	0.5%	$36.55	56
2021-Q4	Increased	7.3M	+94.8%	$320.1M	0.4%	$36.47	59
2021-Q3	Increased	3.7M	+107.4%	$142.4M	0.2%	$31.21	58
2021-Q2	Decreased	1.8M	-34.8%	$71.6M	0.1%	$32.12	0
2021-Q1	Decreased	2.8M	-62.0%	$98.4M	0.1%	$28.40	0
2020-Q4	Increased	7.3M	+83.0%	$267.3M	0.4%	$28.77	57
2020-Q3	Decreased	4M	-5.7%	$149.4M	0.2%	$29.05	0
2020-Q2	Increased	4.2M	+42.6%	$171.7M	0.3%	$31.12	49
2020-Q1	Decreased	3M	-30.7%	$111.9M	0.3%	$28.59	0
2019-Q4	Decreased	4.3M	-14.7%	$200.2M	0.5%	$34.96	0
2019-Q3	Decreased	5M	-8.9%	$213.2M	0.5%	$31.41	0
2019-Q2	Decreased	5.5M	-46.4%	$219.4M	0.5%	$29.11	0
2019-Q1	Increased	10.2M	+20.2%	$427.1M	1.0%	$30.02	58
2018-Q4	First report	8.5M	-	$325M	0.9%	$27.05	0